Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1742-2094
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation ; volume:16 ; number:1 ; day:20 ; month:3 ; year:2019 ; pages:1-12 ; date:12.2019
Journal of neuroinflammation ; 16, Heft 1 (20.3.2019), 1-12, 12.2019

Creator
Becquet, Laurine
Abad, Catalina
Leclercq, Mathilde
Miel, Camille
Jean, Laetitia
Riou, Gaëtan
Couvineau, Alain
Boyer, Olivier
Tan, Yossan-Var
Contributor
SpringerLink (Online service)

DOI
10.1186/s12974-019-1447-y
URN
urn:nbn:de:101:1-2019041321071819952128
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:58 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Becquet, Laurine
  • Abad, Catalina
  • Leclercq, Mathilde
  • Miel, Camille
  • Jean, Laetitia
  • Riou, Gaëtan
  • Couvineau, Alain
  • Boyer, Olivier
  • Tan, Yossan-Var
  • SpringerLink (Online service)

Other Objects (12)

ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis

ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis

Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis

Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis

Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis

Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis

Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis

Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis

Lowering blood cholesterol does not affect neuroinflammation in experimental autoimmune encephalomyelitis

Lowering blood cholesterol does not affect neuroinflammation in experimental autoimmune encephalomyelitis

Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis

Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis

Swertiamarin ameliorates inflammation and oxidative damage in autoimmune encephalomyelitis mouse model

Swertiamarin ameliorates inflammation and oxidative damage in autoimmune encephalomyelitis mouse model

Cellular inhibitor of apoptosis 2 (cIAP2) restricts neuroinflammation during experimental autoimmune encephalomyelitis

Cellular inhibitor of apoptosis 2 (cIAP2) restricts neuroinflammation during experimental autoimmune encephalomyelitis

Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis

Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis

Microglial expression of CD83 governs cellular activation and restrains neuroinflammation in experimental autoimmune encephalomyelitis

Microglial expression of CD83 governs cellular activation and restrains neuroinflammation in experimental autoimmune encephalomyelitis

Related objects